X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11) 11
female (10) 10
male (10) 10
forced expiratory volume (9) 9
middle aged (9) 9
pulmonary disease, chronic obstructive - physiopathology (9) 9
respiratory system (9) 9
index medicus (8) 8
muscarinic antagonists - adverse effects (8) 8
pulmonary disease, chronic obstructive - drug therapy (8) 8
time factors (8) 8
aged (7) 7
bronchodilator agents - adverse effects (7) 7
safety (7) 7
treatment outcome (7) 7
tropanes - adverse effects (7) 7
copd (6) 6
lung - drug effects (6) 6
lung - physiopathology (6) 6
pulmonary disease, chronic obstructive - diagnosis (6) 6
randomized controlled trials as topic (6) 6
severity of illness index (6) 6
symptoms (6) 6
bronchodilator agents - administration & dosage (5) 5
clinical trials, phase iii as topic (5) 5
disease progression (5) 5
efficacy (5) 5
muscarinic antagonists - administration & dosage (5) 5
original research (5) 5
recovery of function (5) 5
tropanes - administration & dosage (5) 5
administration, inhalation (4) 4
adrenergic beta-2 receptor agonists - adverse effects (4) 4
double-blind method (4) 4
drug combinations (4) 4
fixed-dose combinations (4) 4
muscarinic antagonists - therapeutic use (4) 4
obstructive pulmonary-disease (4) 4
respiratory tract diseases (4) 4
tiotropium (4) 4
tropanes - therapeutic use (4) 4
aclidinium (3) 3
adrenergic beta-2 receptor agonists - administration & dosage (3) 3
analysis (3) 3
bronchodilation (3) 3
bronchodilator agents - therapeutic use (3) 3
care and treatment (3) 3
chronic obstructive pulmonary disease (3) 3
circadian rhythm (3) 3
diseases of the respiratory system (3) 3
exacerbations (3) 3
formoterol (3) 3
formoterol fumarate - adverse effects (3) 3
further section (3) 3
long-acting muscarinic antagonist (3) 3
lung diseases, obstructive (3) 3
lung-function (3) 3
multicenter studies as topic (3) 3
pulmonary and respiratory medicine (3) 3
research (3) 3
surveys and questionnaires (3) 3
24-hour (2) 2
aclidinium bromide (2) 2
aclidinium bromide/formoterol fumarate (2) 2
adult (2) 2
bromide/formoterol fumarate (2) 2
classification (2) 2
clinical trials (2) 2
clinical-trials (2) 2
dk/atira/pure/subjectarea/asjc/2700/2740 (2) 2
drug administration schedule (2) 2
dyspnea (2) 2
e-rs (2) 2
formoterol fumarate - administration & dosage (2) 2
international journal of chronic obstructive pulmonary disease (2) 2
laba (2) 2
lama (2) 2
measuring respiratory symptoms (2) 2
nighttime (2) 2
nighttime symptoms (2) 2
oxygen-saturation (2) 2
placebo (2) 2
quality-of-life (2) 2
1506 (1) 1
2 6-month (1) 1
2215 (1) 1
24-hour bronchodilation (1) 1
3 clinical-trials (1) 1
acliform (1) 1
activities of daily living (1) 1
adolescent (1) 1
adrenal cortex hormones - administration & dosage (1) 1
adrenergic beta-2 receptor agonists - therapeutic use (1) 1
age factors (1) 1
air-flow obstruction (1) 1
allergies (1) 1
allergy (1) 1
antagonist (1) 1
anti-infective agents - adverse effects (1) 1
anticholinergics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Respiratory Research, ISSN 1465-9921, 05/2017, Volume 18, Issue 1, pp. 106 - 11
Background: `Clinically important deterioration' (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive... 
Bronchodilation | LAMA | Chronic respiratory disease | LABA | COPD | PLACEBO | EFFICACY | SAFETY | COMPONENTS | QVA149 | ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE | RESPIRATORY SYSTEM | EXACERBATIONS | TIOTROPIUM | FIXED-DOSE COMBINATIONS | Bronchodilator Agents - therapeutic use | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Muscarinic Antagonists - therapeutic use | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Formoterol Fumarate - therapeutic use | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Double-Blind Method | Formoterol Fumarate - adverse effects | Treatment Outcome | Lung - physiopathology | Tropanes - therapeutic use | Clinical Deterioration | Lung - drug effects | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Respiratory function | Stability | Health | Lung diseases | Clinical trials | Patients | Respiratory tract | Studies | Reduction | Dyspnea | Deterioration | Risk assessment | Obstructive lung disease | Formoterol | Chronic obstructive pulmonary disease | Respiration | Research
Journal Article
Respiratory Research, ISSN 1465-9921, 05/2016, Volume 17, Issue 1, p. 61
Journal Article
COPD: Journal of Chronic Obstructive Pulmonary Disease, ISSN 1541-2555, 8/2013, Volume 10, Issue 4, pp. 511 - 522
Journal Article
BMJ Open Respiratory Research, ISSN 2052-4439, 12/2016, Volume 3, Issue 1, p. e000148
BackgroundCough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of... 
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 08/2016, Volume 11, Issue 1, pp. 2041 - 2052
Background: Patients with chronic obstructive pulmonary disease (COPD) experience respiratory symptoms, which impair quality of life. This pooled analysis of... 
Formoterol | Dyspnea | Lung function | Aclidinium | Symptoms | COPD | aclidinium | ACLIFORM | MULTICENTER | SAFETY | E-RS | dyspnea | formoterol | symptoms | MEASURING RESPIRATORY SYMPTOMS | lung function | ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE | RESPIRATORY SYSTEM | CLINICAL-TRIALS | BROMIDE | 2 6-MONTH | FIXED-DOSE COMBINATIONS | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Recovery of Function | Forced Expiratory Volume | Clinical Trials, Phase III as Topic | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Bronchodilator Agents - adverse effects | Tropanes - administration & dosage | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Tropanes - adverse effects | Formoterol Fumarate - adverse effects | Treatment Outcome | Lung - physiopathology | Circadian Rhythm | Randomized Controlled Trials as Topic | Muscarinic Antagonists - administration & dosage | Lung - drug effects | Exercise Tolerance | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Medicine, Experimental | Medical research | Lung diseases, Obstructive | Care and treatment
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1178-2005, 2019, Volume 14, pp. 479 - 491
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2017, Volume 12, pp. 1731 - 1740
Journal Article
Thorax, ISSN 0040-6376, 12/2012, Volume 67, Issue Suppl 2, p. A26
Introduction and Objective Aclidinium bromide is a novel, long-acting, muscarinic antagonist indicated as a maintenance treatment for chronic obstructive... 
Journal Article
ISSN 1176-9106, 05/2016
We investigated the effect of the long-acting muscarinic antagonist aclidinium bromide on chronic obstructive pulmonary disease (COPD) exacerbations by pooling... 
Malalties dels pulmons | Pulmonary diseases | Malalties pulmonars obstructives cròniques | Chronic obstructive pulmonary diseases
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 12/2005, Volume 138, Issue 4, pp. 352 - 352
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 12/2005, Volume 138, Issue 4, pp. 353 - 354
Journal Article
International Archives of Allergy and Immunology, ISSN 1018-2438, 12/2005, Volume 138, Issue 4, pp. 350 - 351
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.